Show simple item record

dc.contributor.authorGirón Ortega, José Antonio
dc.contributor.authorFernández Guerrero, Raquel
dc.contributor.authorMontes de Oca Arjona, Montserrat
dc.contributor.authorGalán Sanchez, Fátima 
dc.contributor.authorPellejero Sagastizábal, Galadriel
dc.contributor.authorMorte Romea, Elena
dc.contributor.authorDe Cueto, Marina
dc.contributor.authorBeltrán Garcia, Margarita
dc.contributor.authorPalacio Baena, Zaira
dc.contributor.authorJiménez Jorge, Silvia
dc.contributor.authorRodríguez Baño, Jesús
dc.contributor.authorRetamar Gentil, Pilar
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-05-28T12:53:27Z
dc.date.available2024-05-28T12:53:27Z
dc.date.issued2024
dc.identifier.issn1532-2742
dc.identifier.issn0163-4453
dc.identifier.urihttp://hdl.handle.net/10498/32409
dc.description.abstractObjectives: To evaluate the appropriateness of antimicrobial treatment and the risk factors for mortality in patients with negative blood cultures (BC), in order to evaluate whether this population would be a suitable target for antimicrobial stewardship (AMS) interventions. Methods: A multicentre prospective cohort study of patients with negative BC in three Spanish hospitals between October 2018 and July 2019 was performed. The main endpoints were the appropriateness of antimicrobial treatment (evaluated by two investigators according to local guidelines) and 30-day mortality. Cox-regression was performed to estimate the association between variables and 30-day mortality. Results: Of 1011 patients in whom BC was obtained, these were negative in 803 (79%) and were included; 30-day mortality was 9% (70 patients); antibiotic treatment was considered inappropriate in 299 (40%) of 747 patients evaluated at day 2, and in 266 (46%) of 573 at day 5–7. The variables independently associated with increased risk of 30-day mortality were higher age (HR 1.05; 95% CI 1.03–1.07), neoplasia (HR 2.73; 95% CI 1.64–4.56), antibiotic treatment in the 48 h prior to BC extraction (HR 2.06; 95% CI 1.23–3.43) and insufficient antibiotic coverage at day 2 after BC obtainment (HR 2.35; 95% CI 1.39–4.00). Urinary, catheter and biliary sources of infection were associated with lower risk (HR 0.40; 95% CI 0.20–0.81). Conclusions: Antimicrobial treatment is frequently inappropriate among patients with negative BC; insufficient antibiotic coverage at day 2 was associated with mortality. These results suggest that patients with negative BC are a suitable population for AS interventions. Antimicrobial treatment in patients with negative blood culture was frequently inappropriate, and inappropriate coverage at day 2 was associated with increased risk of death. These data support the consideration of this population as a potential target for antimicrobial stewardship interventions.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceJournal of Infection - 2024, Vol. 88 n. 2 pp. 95-102es_ES
dc.subjectBlood cultureses_ES
dc.subjectAntimicrobial treatmentes_ES
dc.subjectMortalityes_ES
dc.subjectRisk factorses_ES
dc.subjectAntimicrobial stewardshipes_ES
dc.titleAntibiotic use and outcome in patients with negative blood cultures, a new target population for antimicrobial stewardship interventions: A prospective multicentre cohort (NO-BACT)es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/J.JINF.2023.11.013
dc.relation.projectIDREIPI RD16/0016/0001es_ES
dc.relation.projectIDPI17/01809es_ES
dc.relation.projectIDCB21/13/00087es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional